Ricotti Leonardo, Assaf Tareq, Dario Paolo, Menciassi Arianna
The Biorobotics Institute, Scuola Superiore Sant'Anna, Viale Rinaldo Piaggio 34, 56025, Pontedera (Pisa), Italy.
J Artif Organs. 2013 Mar;16(1):9-22. doi: 10.1007/s10047-012-0660-6. Epub 2012 Sep 20.
A lifelong-implanted and completely automated artificial or bioartificial pancreas (BAP) is the holy grail for type 1 diabetes treatment, and could be a definitive solution even for other severe pathologies, such as pancreatitis and pancreas cancer. Technology has made several important steps forward in the last years, providing new hope for the realization of such devices, whose feasibility is strictly connected to advances in glucose sensor technology, subcutaneous and intraperitoneal insulin pump development, the design of closed-loop control algorithms for mechatronic pancreases, as well as cell and tissue engineering and cell encapsulation for biohybrid pancreases. Furthermore, smart integration of the mentioned components and biocompatibility issues must be addressed, bearing in mind that, for mechatronic pancreases, it is most important to consider how to recharge implanted batteries and refill implanted insulin reservoirs without requiring periodic surgical interventions. This review describes recent advancements in technologies and concepts related to artificial and bioartificial pancreases, and assesses how far we are from a lifelong-implanted and self-working pancreas substitute that can fully restore the quality of life of a diabetic (or other type of) patient.
一种终身植入且完全自动化的人工或生物人工胰腺(BAP)是1型糖尿病治疗的圣杯,甚至对于其他严重病症,如胰腺炎和胰腺癌,也可能是一种终极解决方案。在过去几年里,技术取得了几个重要进展,为实现此类设备带来了新希望,其可行性与葡萄糖传感器技术的进步、皮下和腹腔内胰岛素泵的发展、机电一体化胰腺的闭环控制算法设计,以及生物杂交胰腺的细胞和组织工程及细胞封装密切相关。此外,必须解决上述组件的智能集成和生物相容性问题,同时要记住,对于机电一体化胰腺来说,最重要的是考虑如何在无需定期手术干预的情况下为植入电池充电和补充植入的胰岛素储液器。本综述描述了与人工和生物人工胰腺相关的技术和概念的最新进展,并评估了我们距离能够完全恢复糖尿病(或其他类型)患者生活质量的终身植入且自行工作的胰腺替代品还有多远。